Finance

Lists
A58:ETR
Elevance Health Inc
379,60 €
+0,42%
(+1,60) 1D
14 ოქტ, 09:04:43 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for A58...
Open
379,60 €
High
379,60 €
Low
379,60 €
Mkt. cap
91,54 მლრდ.
Avg. vol.
11,00
Volume
0,00
52-wk high
379,60 €
52-wk low
241,60 €
No. of employees
97 ათ.
Open
379,60 €
High
379,60 €
Low
379,60 €
Mkt. cap
91,54 მლრდ.
Avg. vol.
11,00
Volume
0,00
52-wk high
379,60 €
52-wk low
241,60 €
No. of employees
97 ათ.
News stories
From web sources and news partners
Profile
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
About Elevance Health Inc
CEOგაილ კოზიარა ბუდროხი
Employees96,6 ათ.
Founded1944
Headquartersინდიანაპოლისი, ინდიანა, ამერიკის შეერთებული შტატები
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
50,71 მლრდ.
49,75 მლრდ.
50,18 მლრდ.
50,47 მლრდ.
Cost of goods sold
38,14 მლრდ.
38,06 მლრდ.
35,62 მლრდ.
37,02 მლრდ.
Cost of revenue
38,14 მლრდ.
38,06 მლრდ.
35,62 მლრდ.
37,02 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,65 მლრდ.
10,75 მლრდ.
11,79 მლრდ.
11,04 მლრდ.
Operating expense
10,81 მლრდ.
10,92 მლრდ.
11,90 მლრდ.
11,15 მლრდ.
Total operating expenses
48,95 მლრდ.
48,98 მლრდ.
47,52 მლრდ.
48,17 მლრდ.
Operating income
1,76 მლრდ.
766,00 მლნ.
2,66 მლრდ.
2,30 მლრდ.
Other non operating income
-
-
-
-
EBT including unusual items
1,41 მლრდ.
215,00 მლნ.
2,30 მლრდ.
1,94 მლრდ.
EBT excluding unusual items
1,41 მლრდ.
399,00 მლნ.
2,30 მლრდ.
1,94 მლრდ.
Income tax expense
219,00 მლნ.
-331,00 მლნ.
544,00 მლნ.
483,00 მლნ.
Effective tax rate
15,58%
-153,95%
23,61%
24,94%
Other operating expenses
-
-
-
-
Net income
1,19 მლრდ.
547,00 მლნ.
1,76 მლრდ.
1,46 მლრდ.
Net profit margin
2,34%
1,10%
3,52%
2,90%
Earnings per share
6,03
3,33
12,58
7,45
Interest and investment income
-
-
-
-
Interest expense
-351,00 მლნ.
-367,00 მლნ.
-357,00 მლნ.
-364,00 მლნ.
Net interest expenses
-351,00 მლნ.
-367,00 მლნ.
-357,00 მლნ.
-364,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
2,14 მლრდ.
1,17 მლრდ.
3,02 მლრდ.
2,67 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები